We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
Cap. Flow
+$423M
Cap. Flow %
5.97%
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$188M
2
LH icon
Labcorp
LH
+$183M
3
AGN
Allergan Inc
AGN
+$144M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$93.8M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$82.2M

Top Sells

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$104M
2
CAH icon
Cardinal Health
CAH
+$104M
3
AGN
Allergan plc
AGN
+$80.7M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$60.3M
5
ELV icon
Elevance Health
ELV
+$55.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.3%
2 Consumer Discretionary 5.38%
3 Financials 4.49%
4 Industrials 3.37%
5 Technology 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
1
DELISTED
Endo International plc
ENDP
$411M 5.8%
5,700,751
+1,165,261
+26% +$79.8M
AGN
2
DELISTED
Allergan Inc
AGN
$368M 5.2%
1,732,330
+724,231
+72% +$144M
SLXP
3
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$354M 4.99%
3,076,092
+774,463
+34% +$93.8M
LH icon
4
Labcorp
LH
$25.5B
$303M 4.28%
3,267,555
+2,069,007
+173% +$183M
COV
5
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$224M 3.16%
2,188,510
+1,959,786
+857% +$188M
AGN
6
DELISTED
Allergan plc
AGN
$187M 2.65%
728,397
-323,051
-31% -$80.7M
BKD icon
7
Brookdale Senior Living
BKD
$3.57B
$155M 2.19%
4,234,374
-3,080,525
-42% -$104M
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$12B
$89.4M 1.26%
+988,391
New +$82.2M
CNMD icon
9
CONMED
CNMD
$1.32B
$85.9M 1.21%
1,910,604
+291,937
+18% +$12.2M
ZBH icon
10
Zimmer Biomet
ZBH
$18.7B
$85.2M 1.2%
773,539
+312,896
+68% +$33M
ELV icon
11
Elevance Health
ELV
$82.6B
$80.4M 1.14%
639,832
-449,236
-41% -$55.5M
RCPT
12
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$77.7M 1.1%
634,582
+310,393
+96% +$31.4M
SPY icon
13
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$775B
$73M 1.03%
355,300
+352,127
+11,098% +$70.8M
HR icon
14
Healthcare Realty
HR
$7.56B
$71.8M 1.01%
2,666,042
+185,774
+7% +$4.7M
PRGO icon
15
Perrigo
PRGO
$1.45B
$70.7M 1%
422,893
+322,143
+320% +$50.4M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$73.1B
$70.1M 0.99%
170,765
+54,677
+47% +$21.5M
SPY icon
17
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$775B
$69.5M 0.98%
337,900
+336,396
+22,367% +$67.6M
MCK icon
18
McKesson
MCK
$106B
$63M 0.89%
303,347
+64,118
+27% +$13M
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$57.9M 0.82%
4,492,524
+201,552
+5% +$2.52M
OCR
20
DELISTED
OMNICARE INC
OCR
$56.6M 0.8%
775,593
-41,488
-5% -$2.82M
RAD
21
DELISTED
Rite Aid Corporation
RAD
$56.2M 0.79%
373,926
-59,207
-14% -$6.57M
NBIX icon
22
Neurocrine Biosciences
NBIX
$18.2B
$55M 0.78%
2,461,840
+674,579
+38% +$12.8M
LH icon
23
CALL
Labcorp
LH
$25.5B
$54M 0.76%
+582,000
New +$51.4M
AMRI
24
DELISTED
Albany Molecular Research Inc
AMRI
$52.1M 0.74%
3,200,000
+2,000,000
+167% +$36.7M
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
$52M 0.73%
927,839
+137,504
+17% +$7.23M
1
2 3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.

  • Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
  • Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
  • Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
  • Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
  • Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
  • Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
  • Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.